Clinical trial
Double Blind Crossover Clinical Trial of Nabilone for Agitation in Frontotemporal Dementia
NCT05742698 is registered in ClinicalTrials.gov with Simon Ducharme, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double Blind Crossover Clinical Trial of Nabilone for Agitation in Frontotemporal Dementia
- Lead sponsor
- Simon Ducharme, MD
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- March 7, 2023
- Completion date
- December 31, 2025
- Enrollment
- 3 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
bvftd, frontotemporal dementia, frontotemporal dementia, behavioral variant, ftd, ppa, primary progressive aphasia